Payments to doctors in Australia are to be scrutinised after marketing tactics are exposedBMJ 2011; 343 doi: https://doi.org/10.1136/bmj.d6714 (Published 18 October 2011) Cite this as: BMJ 2011;343:d6714
- Ray Moynihan
- 1Byron Bay, Australia
The Australian Medical Association has said it is to review its policies on disclosure after a former drug industry insider spoke openly on a radio programme about how “doctors are being used to sell drugs to patients.”
The review will look specifically at whether doctors’ payments from companies should be disclosed to patients, said Steve Hambleton, the association’s president.
Brendan Shaw, chief executive of the industry body Medicines Australia, also said that greater transparency would be considered as part of a review of the industry’s self regulatory code of conduct.
Petra Helesic, who marketed drugs for more than a …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial